Table 2. The genotype distribution of the CTLA4 polymorphisms in patients with bacterial infection and non-bacterial infection.

Locus	Genotype	Patients with bacterial infection(n = 61)n(%)	Patients with non-bacterial infection(n = 243)n(%)	Model	OR (95% CI)	p value
rs733618	TT	22(36.07)	90(37.04)	Dominant	1.043(0.582–1.870)	0.888
	CT	29(47.54)	119(48.97)	Recessive	1.205(0.559–2.600)	0.634
	CC	10(16.39)	34(13.99)
rs4553808	AA	38(62.30)	158(65.02)	Dominant	1.125(0.629–2.012)	0.691
	AG	20(32.79)	72(29.63)	Recessive	0.915(0.252–3.318)	1.000*
	GG	3(4.92)	13(5.35)
rs5742909	CC	39(63.93)	165(67.90)	Dominant	1.193(0.663–2.148)	0.555
	CT	21(34.43)	71(29.22)	Recessive	0.562(0.068–4.655)	1.000*
	TT	1(1.64)	7(2.88)
rs231775	GG	23(37.70)	97(39.91)	Dominant	1.098(0.616–1.956)	0.752
	AG	29(47.54)	115(47.33)	Recessive	1.184(0.531–2.639)	0.680
	AA	9(14.75)	31(12.76)
rs3087243	GG	46(75.40)	182(74.88)	Dominant	0.973(0.507–1.865)	0.934
	AG	13(21.31)	47(19.34)	Recessive	0.554(0.123–2.507)	0.748*
	AA	2(3.28)	14(5.76)

^*Fisher's Exact Test;

OR: odds ratio, CI: confidence intervals.